Misoprostol Pill
ApprovedSmall molecule
Misoprostol Pill is one of 70 small molecule programs targeting Abortion. It is currently in Approved.
2
Indications
6
Total Trials
0
Active Trials
69
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
230 competitors in Cesarean Section
#DrugCompanyPhaseTrials
1Misoprostol Pill
UUniversity of North Carolina, Chapel Hill
Approved
Marcaine
IInnocoll
Preclinical
Pitocin
RRetrophin
Preclinical
Naropin
FFresenius Kabi Oncology Ltd.
Preclinical
Dynastat
PfizerPreclinical
Ancef
BBaxter Healthcare Corporation
Preclinical
Nubain
AAultman Health Foundation
Preclinical
Intrathecal Morphine
Pacira Pharmaceuticals, IncPreclinical
Sufenta
LLeaf Vertical Inc.
Preclinical
Demerol
QQuagen
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Pregnancy2 trials
Comparison of Two Different Drug Regimens for Medical Treatment of Early Pregnancy Loss
Unknown status·—·Phase 4·NCT05124314·220 enrolled
Cesarean Section1 trial
Pre Versus Post-operative Misoprostol in Reducing Blood Loss After Cesarean Section
Unknown status·—·Phase 4·NCT05928871·120 enrolled
Misoprostol1 trial
Comparative Study Between Combined Vaginal Misoprostol
Unknown status·—·Phase 1·NCT04981457·60 enrolled
Cervical Ripening1 trial
Misoprostol Versus Effox as Cervical Ripening Agent Prior Surgical Evacuation
Unknown status·—·Phase 2·NCT02738177·90 enrolled
Abortion1 trial
Sublingual vs Vaginal Misoprostol for Termination of First Trimesteric Missed Abortion
Unknown status·—·Phase 1·NCT05001061·288 enrolled
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Misoprostol Pill. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details